Effect of pyratrione (a tyrosine hydroxylase inhibitor) in essential hypertension.
1. A clinical study of pyratrione, a tyrosine hydroxylase inhibitor, has been carried out in essential hypertension. 2. Out of thirty-nine patients who received pyratrione, twenty-eight showed a significant decrease in blood pressure.